These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 33298043

  • 21. Childhood atopic dermatitis: a measurement of quality of life and family impact.
    Aziah MS, Rosnah T, Mardziah A, Norzila MZ.
    Med J Malaysia; 2002 Sep; 57(3):329-39. PubMed ID: 12440273
    [Abstract] [Full Text] [Related]

  • 22. Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective.
    Chia SY, Wee LWY, Koh MJA.
    Dermatol Ther; 2021 May; 34(3):e14933. PubMed ID: 33751751
    [Abstract] [Full Text] [Related]

  • 23. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
    Chan S, Cornelius V, Cro S, Harper JI, Lack G.
    JAMA Pediatr; 2020 Jan 01; 174(1):29-37. PubMed ID: 31764962
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Educational intervention and atopic dermatitis: impact on quality of life and treatment.
    Muzzolon M, Imoto RR, Canato M, Abagge KT, de Carvalho VO.
    Asia Pac Allergy; 2021 Apr 01; 11(2):e21. PubMed ID: 34007831
    [Abstract] [Full Text] [Related]

  • 27. Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children.
    Niseteo T, Hojsak I, Ožanić Bulić S, Pustišek N.
    Nutrients; 2024 Aug 24; 16(17):. PubMed ID: 39275147
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Disease severity and associated family impact in childhood atopic dermatitis.
    Balkrishnan R, Housman TS, Carroll C, Feldman SR, Fleischer AB.
    Arch Dis Child; 2003 May 24; 88(5):423-7. PubMed ID: 12716715
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Quality of life of pediatric patients with atopic dermatitis and their caregivers.
    El Achkar Mello ME, Simoni AG, Rupp ML, de Azevedo Simões PWT, de Souza Pires MM.
    Arch Dermatol Res; 2023 Aug 24; 315(6):1571-1576. PubMed ID: 36723680
    [Abstract] [Full Text] [Related]

  • 32. Frequent Versus Infrequent Bathing in Pediatric Atopic Dermatitis: A Randomized Clinical Trial.
    Cardona ID, Kempe EE, Lary C, Ginder JH, Jain N.
    J Allergy Clin Immunol Pract; 2020 Mar 24; 8(3):1014-1021. PubMed ID: 31733336
    [Abstract] [Full Text] [Related]

  • 33. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.
    J Eur Acad Dermatol Venereol; 2006 Mar 24; 20(3):248-54. PubMed ID: 16503881
    [Abstract] [Full Text] [Related]

  • 34. The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Ragamin A, Zhang J, Pasmans SGMA, Schappin R, Romeijn GLE, van Reusel MA, Oosterhaven JAF, Schuttelaar MLA.
    Br J Dermatol; 2024 May 17; 190(6):867-875. PubMed ID: 38262143
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Predictors of treatment success in children with difficult to treat atopic dermatitis using a personalized integrative multidisciplinary (PIM) treatment programme.
    Fieten KB, Schappin R, Zijlstra WT, Rijssenbeek-Nouwens L, Meijer Y, Pasmans SGMA.
    J Eur Acad Dermatol Venereol; 2019 Feb 17; 33(2):376-383. PubMed ID: 30198582
    [Abstract] [Full Text] [Related]

  • 39. Children with Dry Skin and Atopic Predisposition: Outcome Measurement with Validated Scores for Atopic Dermatitis.
    Sawatzky S, Schario M, Stroux A, Lünnemann L, Zuberbier T, Blume-Peytavi U, Garcia Bartels N.
    Skin Pharmacol Physiol; 2016 Feb 17; 29(3):148-56. PubMed ID: 27271265
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.